Search Results

substantial reduction in cancer diagnoses following the onset of the COVID-19 pandemic. This indicates that COVID-19 may have impacted and prevented patients from being diagnosed early on. ONCOassist aims to make life easier for both oncology professionals as

today in support of funding the Cancer Moonshot initiative. The letter details the urgent need for funding especially in light of delayed screenings, treatments, and research caused by the COVID-19 pandemic. It also makes clear the unique opportunity to

your family, pay rent, absorb income loss, or overcome the obstacles that exist within the healthcare system. The COVID-19 pandemic has only deepened health injustice and the trauma of poverty in this country. This impact is reflected in the experience

posters included topics such as CAR T, stem cell transplantation, treatment utilization trends, opioid prescribing trends, e-cigarettes, disparities, and the ongoing impact of COVID-19. “The poster session presented by the NCCN Oncology Research Program

Forum: Advancing Oncology Nursing in Hematologic Malignancies, on Friday, October 8, 2021, to provide nurses with comprehensive and clinically relevant information to optimize care for patients with blood cancers. “In response to the ongoing COVID-19

excellence and spirit he and his department show every year, allowing NCCN to continue providing leading-edge continuing education activities, guideline panel update meet-ings, patient webinars, and other offerings, in spite of the COVID-19 pandemic. Both

session on “Health System Recruitment and Retention Strategies” (synopsis available on JNCCN.org ), speakers pointed out how the COVID-19 pandemic and its aftermath have caused many in healthcare to reassess their lives and priorities. The loss of staff

workplace that includes support for people with cancer and their caregivers. The program, which also featured a virtual attendance option, examined how workplace norms and expectations have changed in recent years, particularly since the onset of the COVID

-based palliative care support has been limited, although with increased telemedicine funding (amplified by COVID-19) and the establishment of “virtual” telemedicine palliative care clinics, there has been improvement. In patients with solid organ malignancy, these

target sample size of 80 per group because recruitment was halted as a result of government and hospital directives to cease research due to the COVID-19 pandemic (March 12, 2020). Our overall recruitment period was <1 year. Rates of attrition were 25